BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

658 related articles for article (PubMed ID: 18557922)

  • 1. Environmental enrichment ameliorates a motor coordination deficit in a mouse model of Rett syndrome--Mecp2 gene dosage effects and BDNF expression.
    Kondo M; Gray LJ; Pelka GJ; Christodoulou J; Tam PP; Hannan AJ
    Eur J Neurosci; 2008 Jun; 27(12):3342-50. PubMed ID: 18557922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Environmental enrichment alters locomotor behaviour and ventricular volume in Mecp2 1lox mice.
    Nag N; Moriuchi JM; Peitzman CG; Ward BC; Kolodny NH; Berger-Sweeney JE
    Behav Brain Res; 2009 Jan; 196(1):44-8. PubMed ID: 18687363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hippocampal synaptic plasticity is impaired in the Mecp2-null mouse model of Rett syndrome.
    Asaka Y; Jugloff DG; Zhang L; Eubanks JH; Fitzsimonds RM
    Neurobiol Dis; 2006 Jan; 21(1):217-27. PubMed ID: 16087343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of postnatal dietary choline supplementation on motor regional brain volume and growth factor expression in a mouse model of Rett syndrome.
    Nag N; Mellott TJ; Berger-Sweeney JE
    Brain Res; 2008 Oct; 1237():101-9. PubMed ID: 18778693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Behavioral and anatomical abnormalities in Mecp2 mutant mice: a model for Rett syndrome.
    Stearns NA; Schaevitz LR; Bowling H; Nag N; Berger UV; Berger-Sweeney J
    Neuroscience; 2007 May; 146(3):907-21. PubMed ID: 17383101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted delivery of an Mecp2 transgene to forebrain neurons improves the behavior of female Mecp2-deficient mice.
    Jugloff DG; Vandamme K; Logan R; Visanji NP; Brotchie JM; Eubanks JH
    Hum Mol Genet; 2008 May; 17(10):1386-96. PubMed ID: 18223199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mecp2 deficiency is associated with learning and cognitive deficits and altered gene activity in the hippocampal region of mice.
    Pelka GJ; Watson CM; Radziewic T; Hayward M; Lahooti H; Christodoulou J; Tam PP
    Brain; 2006 Apr; 129(Pt 4):887-98. PubMed ID: 16467389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postnatal changes in serotonergic innervation to the hippocampus of methyl-CpG-binding protein 2-null mice.
    Isoda K; Morimoto M; Matsui F; Hasegawa T; Tozawa T; Morioka S; Chiyonobu T; Nishimura A; Yoshimoto K; Hosoi H
    Neuroscience; 2010 Feb; 165(4):1254-60. PubMed ID: 19932741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoamine deficits in the brain of methyl-CpG binding protein 2 null mice suggest the involvement of the cerebral cortex in early stages of Rett syndrome.
    Santos M; Summavielle T; Teixeira-Castro A; Silva-Fernandes A; Duarte-Silva S; Marques F; Martins L; Dierssen M; Oliveira P; Sousa N; Maciel P
    Neuroscience; 2010 Oct; 170(2):453-67. PubMed ID: 20633611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methyl CpG-binding protein 2 (a mutation of which causes Rett syndrome) directly regulates insulin-like growth factor binding protein 3 in mouse and human brains.
    Itoh M; Ide S; Takashima S; Kudo S; Nomura Y; Segawa M; Kubota T; Mori H; Tanaka S; Horie H; Tanabe Y; Goto Y
    J Neuropathol Exp Neurol; 2007 Feb; 66(2):117-23. PubMed ID: 17278996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell-specific expression of wild-type MeCP2 in mouse models of Rett syndrome yields insight about pathogenesis.
    Alvarez-Saavedra M; Sáez MA; Kang D; Zoghbi HY; Young JI
    Hum Mol Genet; 2007 Oct; 16(19):2315-25. PubMed ID: 17635839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The ups and downs of BDNF in Rett syndrome.
    Sun YE; Wu H
    Neuron; 2006 Feb; 49(3):321-3. PubMed ID: 16446133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early postnatal behavioral changes in the Mecp2-308 truncation mouse model of Rett syndrome.
    De Filippis B; Ricceri L; Laviola G
    Genes Brain Behav; 2010 Mar; 9(2):213-23. PubMed ID: 19958389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postnatal loss of methyl-CpG binding protein 2 in the forebrain is sufficient to mediate behavioral aspects of Rett syndrome in mice.
    Gemelli T; Berton O; Nelson ED; Perrotti LI; Jaenisch R; Monteggia LM
    Biol Psychiatry; 2006 Mar; 59(5):468-76. PubMed ID: 16199017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improvement in motor and exploratory behavior in Rett syndrome mice with restricted ketogenic and standard diets.
    Mantis JG; Fritz CL; Marsh J; Heinrichs SC; Seyfried TN
    Epilepsy Behav; 2009 Jun; 15(2):133-41. PubMed ID: 19249385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cognitive and social functions and growth factors in a mouse model of Rett syndrome.
    Schaevitz LR; Moriuchi JM; Nag N; Mellot TJ; Berger-Sweeney J
    Physiol Behav; 2010 Jun; 100(3):255-63. PubMed ID: 20045424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cholinergic hypofunction in MeCP2-308 mice: beneficial neurobehavioural effects of neonatal choline supplementation.
    Ricceri L; De Filippis B; Fuso A; Laviola G
    Behav Brain Res; 2011 Aug; 221(2):623-9. PubMed ID: 21457731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for abnormal early development in a mouse model of Rett syndrome.
    Santos M; Silva-Fernandes A; Oliveira P; Sousa N; Maciel P
    Genes Brain Behav; 2007 Apr; 6(3):277-86. PubMed ID: 16848781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breeding and maintenance of an Mecp2-deficient mouse model of Rett syndrome.
    Jugloff DG; Logan R; Eubanks JH
    J Neurosci Methods; 2006 Jun; 154(1-2):89-95. PubMed ID: 16439027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A methyl-CpG-binding protein 2-enhanced green fluorescent protein reporter mouse model provides a new tool for studying the neuronal basis of Rett syndrome.
    Schmid RS; Tsujimoto N; Qu Q; Lei H; Li E; Chen T; Blaustein CS
    Neuroreport; 2008 Mar; 19(4):393-8. PubMed ID: 18287934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.